Author(s):
Prema. V, Sujitha. S, Abinaya. N, Sudhir. R
Email(s):
premapharmchemistry@gmail.com
DOI:
10.52711/2231-5691.2026.00072 
Address:
Prema. V1*, Sujitha. S2, Abinaya. N2, Sudhir. R2
1Department of Pharmaceutical Chemistry, K.K. College of Pharmacy, Chennai, Tamil Nadu, India.
2Department of Pharmacy Practice, K.K. College of Pharmacy, Chennai, Tamil Nadu, India.
*Corresponding Author
Published In:
Volume - 16,
Issue - 4,
Year - 2026
ABSTRACT:
Dermatophytosis, or ringworm, is one of the most common fungal infections of the skin, hair, and nails. It is usually treated with antifungal creams or oral drugs, but in recent years a new species, Trichophyton indotineae, has become a major concern. First identified in India, this fungus spreads quickly, causes stubborn infections, and shows resistance to many standard antifungal drugs, especially terbinafine. Infections caused by T. indotineae have now been reported worldwide, making it an emerging public health challenge. This review explains the rise of T. indotineae, its drug-resistance mechanisms, treatment options, and the global impact of its spread. It also highlights the gaps in current knowledge and explores possible future strategies for managing these difficult infections.
Cite this article:
Prema. V, Sujitha. S, Abinaya. N, Sudhir. R. Trichophyton indotineae — An Emerging, often Terbinafine-Resistant Dermatophyte: A Contemporary Review. Asian Journal of Pharmaceutical Research. 2026; 16(4):503-6. doi: 10.52711/2231-5691.2026.00072
Cite(Electronic):
Prema. V, Sujitha. S, Abinaya. N, Sudhir. R. Trichophyton indotineae — An Emerging, often Terbinafine-Resistant Dermatophyte: A Contemporary Review. Asian Journal of Pharmaceutical Research. 2026; 16(4):503-6. doi: 10.52711/2231-5691.2026.00072 Available on: https://asianjpr.com/AbstractView.aspx?PID=2026-16-4-19
11. REFERENCES:
1. Sonego B, Corio A, Mazzoletti V, Zerbato V, Benini A, di Meo N, et al. Trichophyton indotineae, an Emerging Drug-Resistant Dermatophyte: A Review of the Treatment Options. J Clin Med. 2024; 13(6): 3558.
2. Havlickova B, Craika V, Friedrich M. Epidemiological trends in skin mycoses worldwide. Mycoses. 2008; 51 Suppl 4:2-15.
3. Gupta AK, Venkataraman M, Hall DC, Cooper EA. The emergence of Trichophyton indotineae: Implications for clinical practice. Int J Dermatol. 2022; 62(3):e16362.
4. Bhattacharya S, Nguyen HC, Piguet V, Gupta A. Trichophyton indotineae: Epidemiology, antifungal resistance and antifungal stewardship strategies. J Eur Acad Dermatol Venereol. 2025; 39(7): e1125.
5. De Marco A, Liguori G, Cafarchia C, Caggiano G. Cutaneous Infections Caused by Trichophyton indotineae: Case Series and Systematic Review. J Fungi. 2025; 11(2): e215.
6. McTaggart LR, Cronin K, Ruscica S, Kus JV. Emergence of terbinafine-resistant Trichophyton indotineae in Ontario, Canada, 2014–2023. J Clin Microbiol. 2024; 62(11): e01523-24.
7. Zhan F, Li M, Lv G, et al. Genomic epidemiology and antifungal resistance of emerging Trichophyton indotineae in China. Front Cell Infect Microbiol. 2025.
8. Uhrlaß S, Verma SB, Gräser Y, Rezaei-Matehkolaei A, Hatami M, Schaller M, et al. Trichophyton indotineae—An Emerging Pathogen Causing Recalcitrant Dermatophytoses in India and Worldwide—A Multidimensional Perspective. Journal of Fungi [Internet]. 2022 Jul 1; 8(7): 757. Available from: https://www.mdpi.com/2309-608X/8/7/757/htm
9. Kano R, Kimura U, Kakurai M, Hiruma J, Kamata H, Suga Y, Harada K. Trichophyton indotineae sp. nov.: A New Highly Terbinafine-Resistant Anthropophilic Dermatophyte Species. Mycopathologia. 2020 Dec; 185(6): 947-958.
10. Tang C, Kong X, Ahmed SA, Thakur R, Chowdhary A, Nenoff P, Uhrlass S, Verma SB, Meis JF, Kandemir H, Kang Y, de Hoog GS. Taxonomy of the Trichophyton mentagrophytes/T. interdigitale Species Complex Harboring the Highly Virulent, Multiresistant Genotype T. indotineae. Mycopathologia. 2021 Jun; 186(3): 315-326.
11. Rudramurthy, S. M., Shaw, D., Shankarnarayan, S. A., Abhishek, & Dogra, S. Comprehensive Taxonomical Analysis of Trichophyton mentagrophytes/interdigitale. Complex of Human and Animal Origin from India. Journal of Fungi, 2020; 9(5): 577.
12. Marbaniang YV, Leto D, Almohri H, Hasan MR. Treatment and diagnostic challenges associated with the novel and rapidly emerging antifungal-resistant dermatophyte, Trichophyton indotineae. Humphries RM, editor. Journal of Clinical Microbiology. 2025 Jun 11; 63(6).
13. Ribeiro A, Silke Uhrlaß, Pietro Nenoff, Jeremy, Saiful M, Srikumar Goturu, et al. Global Emergence of Antifungal‐Resistant Dermatophytosis Caused by Trichophyton indotineae (Formerly T. mentagrophytesITS Genotype VIII): A Genomic Investigation Involving 14 Countries. Mycoses. 2025 Aug 1; 68(8).
14. Mackenzie A, Mackenzie J, Mackenzie C. Trichophyton indotineae: Epidemiology, antifungal resistance and antifungal stewardship strategies. J Eur Acad Dermatol Venereol. 2025;39(Suppl 7):1-12.
15. Singh A, Chowdhary A. Emerging dermatophyte Trichophyton indotineae in India: Epidemiology and antifungal susceptibility. Indian J Dermatol Venereol Leprol. 2022; 88(4): 452-60. doi:10.25259/IJDVL_1090_21
16. Nenoff P, Verma SB, Vasani R, et al. Naftifine hydrochloride gel 2% for the treatment of Trichophyton indotineae infections. J Drugs Dermatol. 2023; 22(5): 456-62.
17. Caplan AS. Notes from the Field: First Reported U.S. Cases of Tinea Caused by Trichophyton indotineae — New York City, December 2021–March 2023. MMWR Morbidity and Mortality Weekly Report [Internet]. 2023 [cited 2023 May 24];72. Available from: https://www.cdc.gov/mmwr/volumes/72/wr/mm7219a4.htm
18. Cañete-Gibas C, Mele J, Patterson H, Sanders C, Ferrer D, Garcia V, et al. Terbinafine-Resistant Dermatophytes and the Presence of Trichophyton indotineae in North America. Journal of Clinical Microbiology. 2023 Jul 11; 61(8).
19. Jabet A, Chiarabini T, Hennequin C, Bouscarat F, Valin N, Cruchet R, Boo N, Chanal J, Schuttler C, Kirstetter M, Normand AC, Fekkar A, Pourcher V, Piarroux R, Monsel G. Autochthonous transmission of Trichophyton indotineae through sexual contact, France, 2024. Euro Surveill. 2025 Jul; 30(26):2500416. 5.
20. Caplan AS, Todd GC, Zhu Y, Sikora M, Akoh CC, Jakus J, et al. Clinical Course, Antifungal Susceptibility, and Genomic Sequencing of Trichophyton indotineae. JAMA Dermatology. 2024 Jul 1; 160(7): 701–1.
21. Kaplan E, Bingöl O, Kandemir H, Karakoyun AS, Durdu M, Ilkit M. qPCR-Based Molecular Detection of Trichophyton indotineae by Targeting Divergent Sequences. Mycopathologia. 2025 Apr 3; 190(2): 32. 7.
22. Tang C, Ahmed SA, Deng S, Zhang L, Zoll J, Abdullah, et al. Detection of emerging genotypes in Trichophyton mentagrophytes species complex: A proposal for handling biodiversity in dermatophytes. 2022 Aug 23; 13. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445586/
23. Sacheli, R., Egrek, S., El Moussaoui, K., Kurt, B., Machowski, E., Harag, S., & Hayette, M.-P. National Belgian Study on Terbinafine Resistance in Trichophyton interdigitale/ mentagrophytes/ indotineae (2022–2023): Epidemiology and Molecular Features. Journal of Fungi. 2025; 11(9): 676. 8.
24. Kong X, Tang C, Ashutosh Kumar Singh, Ahmed SA, Abdullah, Chowdhary A, et al. Antifungal Susceptibility and Mutations in the Squalene Epoxidase Gene in Dermatophytes of the Trichophyton mentagrophytes Species Complex. 2021 Jul 16; 65(8): 9.
25. Gupta AK, None Susmita, Nguyen HC, Liddy A, Talukder M, Wang T, et al. Trichophyton indotineae: Epidemiology, antifungal resistance and antifungal stewardship strategies. Journal of the European Academy of Dermatology and Venereology. 2025 Jul 4;
26. Peres MTA, Padovan ACB, de Lima SS, et al. Squalene epoxidase gene mutations in Trichophyton indotineae isolates. Antimicrob Agents Chemother. 2024; 68(3): e0156723. doi:10.1128/aac.01567-23.
27. Mahmood HR, Masoomeh Shams-Ghahfarokhi, Mehdi Razzaghi-Abyaneh. Computational analysis of missense mutations in squalene epoxidase associated with terbinafine resistance in clinically reported dermatophytes. Scientific Reports. 2025 May 28; 15(1).
28. Chowdhary A, Singh A, Kaur A, Khurana A. The emergence and worldwide spread of the species Trichophyton indotineae causing difficult-to-treat dermatophytosis: A new challenge in the management of dermatophytosis. Plos Pathogens. 2022 Sep; 18(9): e1010795.
29. Leeyaphan C, Saengthong-Aram P, Laomoleethorn J, Phinyo P, Lumkul L, Bunyaratavej S. Therapeutic Outcomes in Patients with Trichophyton indotineae: A Systematic Review and Meta-Analysis of Individual Patient Data. Mycoses. 2025 Apr; 68(4): e70048. 10.
30. Gupta AK, Cooper EA, Wang T, Ravi SP, Lincoln SA, Piguet V, et al. Detection of Squalene Epoxidase Mutations in United States Patients with Onychomycosis: Implications for Management. Journal of Investigative Dermatology. 2023 May 24; 143(12): 2476-2483.e7.
31. Dos Santos AR, Uhrlaß S, Nenoff P, Gold JAW, Bhuiyan MSI, Goturu S, Gade L, Bagal UR, Singal A, Parnell L, Schwem B, Chiller T, Litvintseva AP, Chow NA, Verma SB. Global Emergence of Antifungal-Resistant Dermatophytosis Caused by Trichophyton indotineae (Formerly T. mentagrophytes ITS Genotype VIII): A Genomic Investigation Involving 14 Countries. Mycoses. 2025 Aug; 68(8): 70101. 11.
32. Caplan AS, Todd GC, Zhu Y, Sikora M, Akoh CC, Jakus J, et al. Clinical Course, Antifungal Susceptibility, and Genomic Sequencing of Trichophyton indotineae. JAMA Dermatology. 2024 Jul 1; 160(7): 701–1.